What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future? (Q26795518)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: December 2014)

edit

Language	Label	Description	Also known as
English	What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?	scientific article (publication date: December 2014)

Statements

instance of

scholarly article

0 references

title

What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future? (English)

0 references

main subject

future

1 reference

based on heuristic

inferred from title

author name string

Mohamed Ismat Abdulmajed

series ordinal

1

0 references

Eyüp Burak Sancak

series ordinal

2

0 references

Berkan Reşorlu

series ordinal

3

0 references

Gydhia Zuhair Al-Chalaby

series ordinal

4

0 references

language of work or name

English

0 references

publication date

December 2014

0 references

published in

Turkish Journal of Urology

0 references

volume

40

0 references

issue

4

0 references

page(s)

228-32

0 references

cites work

Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

7 April 2017

Cancer statistics, 2008

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

7 April 2017

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: a prospective comparison to the standard approach

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Understanding bladder cancer death: tumor biology versus physician practice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

The global burden of urinary bladder cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Detection of tumours of the urinary tract in voided urine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Bladder cancer: clinical and pathological profile

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer tr

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Urine markers for bladder cancer surveillance: a systematic review

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Prognostic markers in muscle invasive bladder cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Utilization of nuclear matrix proteins for cancer diagnosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Bladder tumors. Treated natural history.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 September 2017

Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

31 May 2018

Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

31 May 2018

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 November 2018

A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 November 2018

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 November 2018

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 November 2018

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4548372

retrieved

28 November 2018

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right Catch

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should we abandon the FISH test?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superficial urothelial (umbrella) cells. A potential cause of abnormal DNA ploidy results in urine specimens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dickkopf-1 levels in Turkish patients with bladder cancer and its association with clinicopathological features

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of bladder cancer recurrence by microsatellite analysis of urine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

False-positive results of the NMP22 test due to hematuria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urine detection of survivin and diagnosis of bladder cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26328183

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.5152/TUD.2014.60973

0 references

PMC publication ID

4548372

0 references

PubMed publication ID

26328183

0 references

ResearchGate publication ID

281515873

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26795518&oldid=1536861998"